24
Participants
Start Date
March 31, 2015
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
Intranasal oxytocin
This is a double-blind placebo controlled 2x2 study. Subjects will receive OT for 5 consecutive days during their 7 day stay. This will be followed by a wash out period of 4-6 weeks.
Placebo
This is a double-blind placebo controlled 2x2 study. Placebo will be given via intranasal spray, one spray in each nostril daily x 5 days. One month interval between arms of treatment.
University of Florida, Gainesville
University of Kansas Medical Center, Kansas City
University of California, Irvine, Orange
National Institutes of Health (NIH)
NIH
University of Florida
OTHER